VanEvery, Hannah http://orcid.org/0000-0002-0778-0607
Franzosa, Eric A. http://orcid.org/0000-0002-8798-7068
Nguyen, Long H. http://orcid.org/0000-0002-5436-4219
Huttenhower, Curtis http://orcid.org/0000-0002-1110-0096
Article History
Accepted: 23 August 2022
First Online: 5 October 2022
Competing interests
: C.H. is a member of the scientific advisory boards of Seres Therapeutics and Empress Therapeutics. The other authors declare no competing interests.